F
Factor V HR2 |
Factor V Leiden |
Factor VII |
Factor XIII |
FGFR1(8p11) for Myeloid and Lymphoid Neoplasms with Eosinophilia (HES/CEL) |
FGFR3/IGH t(4;14)(4p16,14q32) for Multiple Myeloma prognosis |
β Fibrinogen |
FIP1L1/CHIC2/PDGFR A(4q12) for Myeloid and Lymphoid Neoplasms with Eosinophilia (HES/CEL) |
FIP1L1-PDGFRA Exon 9 ,10,11,12,13 for Clonal Eosinophilia |
FLT3-D835 Mutation for AML (prognostic marker) |
FLT3-ITD Mutation for AML (prognostic marker) |
5- Fluorouracil ( 5-FU) toxicity DPYD IVS 14+1 G>A polymorphism |
Follicular Lymphoma panel at diagnosis ( 12-15 CD markers) |
Foreign bodies/ culture |